Company & Sponsor Intelligence
University of Maryland, Baltimore
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed0
Countries1
Therapeutic footprint
autism
Indexed studies
NCT01995825Lamotrigine Bioequivalence
epilepsy · United StatesPHASE4
epilepsy · United StatesPHASE4
NCT02369770Sensory-Motor Rehabilitation Post Stroke
stroke · United StatesNA
stroke · United StatesNA
NCT03300128Incredible Years Program for Parents of Children with Autism
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →